Beginning this month, there is a 45 day window for physicians and teaching hospitals to review the data that pharmaceutical companies, biological makers, and device makers have reported about them to the Centers for Medicare and Medicaid Services (CMS) as part of the Open Payments program. [More…]
- Activities▼
- Education Hubs▼
-
- Alzheimer’s Disease
- Cardiology
- COVID-19
- Dermatology
- Diversity & Inclusion
- Gastroenterology
- Hematology
- Immunodeficiency Disorders
- Infectious Disease
- Liver Disease
- Migraine
- Multiple Sclerosis
- Neuropsychiatric
- Oncology
- Ophthalmology
- Pain Management
- Pediatrics
- Pharmacist Central
- Psoriatic Arthritis
- Rare Diseases
- Respiratory
- Rheumatology
- Sleep Disorders
- Virtual Education
-
- Services▼
- News▼
- ▼